Loading…
Morepen Laboratories (MOREPENLAB)₹99.15+5.00%Pharmaceuticals
At the end of the Sep 2026 quarter, Morepen Laboratories' shareholders were: promoters 35.63%, FIIs 3.44%, DIIs 1.69%, government 0.01%, public 59.23%. Promoter holding is unchanged on the quarter. FII holding is up 1.81 percentage points from 1.63% a year earlier. 0.00% of promoter shares were pledged. It had 4,03,903 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.19% | 38.19% | 38.19% | 35.63% | 35.63% | 35.63% | 35.63% | 35.63% | 35.63% | 35.63% | 35.63% | 35.63% |
| FIIs | 2.12% | 1.86% | 1.68% | 2.09% | 2.23% | 1.95% | 1.73% | 1.63% | 1.63% | 1.60% | 1.47% | 3.44% |
| DIIs | 2.20% | 2.14% | 2.13% | 1.68% | 1.63% | 1.66% | 1.49% | 1.48% | 1.24% | 1.24% | 1.27% | 1.69% |
| Government | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 57.48% | 57.80% | 57.99% | 60.59% | 60.50% | 60.75% | 61.14% | 61.25% | 61.49% | 61.52% | 61.62% | 59.23% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 3,04,267 | 3,35,995 | 3,48,741 | 4,30,898 | 4,48,329 | 4,68,826 | 4,61,147 | 4,61,820 | 4,53,104 | 4,47,254 | 4,34,881 | 4,03,903 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Pinfold Overseas Limited | Public | 6.40% | −0.64 |
| Scope Credits And Financial Services Pvt. Ltd. | Promoter | 2.85% | 0.00 |
| Concept Credits And Consultants Pvt. Ltd. | Promoter | 2.83% | 0.00 |
| Brook Investments And Financial Services Pvt. Ltd | Promoter | 2.76% | 0.00 |
| Solace Investments And Financial Services Pvt. Ltd. | Promoter | 2.76% | 0.00 |
| Solitary Investments And Financial Services Pvt. Ltd. | Promoter | 2.75% | 0.00 |
| Mid Med Financial Services And Investments Pvt. Ltd. | Promoter | 2.72% | 0.00 |
| React Investments And Financial Services Pvt. Ltd. | Promoter | 2.72% | 0.00 |
| Epitome Holdings Pvt.Ltd. | Promoter | 2.64% | 0.00 |
| Seed Securities And Services Pvt. Ltd. | Promoter | 2.60% | 0.00 |
| Square Investments And Financial Services Pvt. Ltd. | Promoter | 2.59% | 0.00 |
| Morepen Laboratories Limited | Public | 1.03% | 0.00 |
| Sushil Suri | Promoter | 1.01% | 0.00 |
| Anju Suri | Promoter | 0.95% | 0.00 |
| Liquid Holdings Pvt. Ltd. | Promoter | 0.92% | 0.00 |
| Sonia Pankaj Bajaj | Promoter | 0.67% | 0.00 |
| Sanjay Suri | Promoter | 0.61% | 0.00 |
| Sunita Suri | Promoter | 0.58% | 0.00 |
| Mamta Suri | Promoter | 0.55% | 0.00 |
| Varun Suri | Promoter | 0.55% | 0.00 |
| Sanjay Suri (Sanjay Suri Sons Huf) | Promoter | 0.38% | 0.00 |
| Shalu Suri | Promoter | 0.37% | 0.00 |
| Anubhav Suri (Arun Suri Sons Huf) | Promoter | 0.27% | 0.00 |
| Sushil Suri (Sushil Suri Sons Huf) | Promoter | 0.22% | 0.00 |
| Gulfy Malhotra | Promoter | 0.21% | 0.00 |
Promoters held 35.63% of Morepen Laboratories at the end of the Sep 2026 quarter, the same as a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 3.44% (up 1.97 percentage points from 1.47% a quarter earlier) and domestic institutions (DIIs) held 1.69% (up 0.42 percentage points from 1.27% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Morepen Laboratories had 4,03,903 shareholders at the end of the Sep 2026 quarter, against 4,61,820 a year earlier.
Pinfold Overseas Limited (Public) held 6.40% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.